SIGA Technologies
SIGA
#8827
Rank
A$0.32 B
Marketcap
A$4.55
Share price
1.43%
Change (1 day)
-64.58%
Change (1 year)

Earnings for SIGA Technologies (SIGA)

Earnings in 2026 (TTM): -A$17.23 Million

According to SIGA Technologies's latest financial reports the company's current earnings are A$53.65 Million. In 2025 the company made an earning of A$33.71 Million a decrease over its 2024 earnings that were of A$99.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for SIGA Technologies from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$17.23 Million-151.07%
2025 A$33.71 M-66.13%
2024 A$99.55 M-16.31%
2023 A$0.11 B89.48%
2022 A$62.78 M-50.38%
2021 A$0.12 B16.22%
2020 A$0.10 B1268.64%
2019 A$7.95 M-98.69%
2018 A$0.60 B-1912.24%
2017 -A$33.53 Million-7.91%
2016 -A$36.41 Million-30.38%
2015 -A$52.3 Million-82.62%
2014 -A$0.31 Billion796.54%
2013 -A$33.56 Million5.18%
2012 -A$31.91 Million-28.53%
2011 -A$44.65 Million
2009 -A$16.9 Million35.95%
2008 -A$12.43 Million17.07%
2007 -A$10.62 Million9.58%
2006 -A$9.69 Million168.94%
2005 -A$3.61 Million-71.48%
2004 -A$12.64 Million67.71%
2003 -A$7.54 Million57.35%
2002 -A$4.79 Million3.73%
2001 -A$4.62 Million-54.2%
2000 -A$10.08 Million105.09%
1999 -A$4.92 Million-33.58%
1998 -A$7.4 Million477.78%
1997 -A$1.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-A$0.19 Billion 1,075.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-A$0.32 Billion 1,905.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.47 Billion 2,825.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.52 Million-27.36%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$0.55 Billion 3,322.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.14 Billion 753.84%๐Ÿ‡บ๐Ÿ‡ธ USA